Green Hygienics Holdings Inc. announced the appointment of three experienced professionals to its management team. The addition of the following individuals will be key in supporting the Company's strategy to advancing its position becoming a leader in the North American Hemp Industry. Kyle MacKinnon - Chief Operating Officer: Mr. MacKinnon has a multi-faceted and in-depth understanding of the CBD Industry, including vast knowledge of cannabis processing.

Previously, as the Business Development Manager for Advanced Extraction, a leader in CO2 Supercritical Fluid Extraction systems, Kyle built relationships with some of the largest Cannabis companies in the world and helped to guide the company through rapid growth and regulatory challenges in the technology and processing sectors of the Cannabis industry. This firsthand knowledge and experience is invaluable in supporting the Company in developing its own processing capabilities. As COO Kyle will assist the company in all areas of day to day business operations.

With over 20 years Sales and Management experience, Kyle is well suited to drive business development, maintain administrative efforts, deliver superior and sustainable product lines, and provide a platform for strong growth. Todd Mueller - Chief Financial Officer: Mueller is a seasoned executive who has held executive senior level positions for both private and public traded companies during his over 30-year career. For the past 15 years, Todd has worked as a fractional CFO for a variety of client companies providing his talents to build highly effective financial processes and procedures to handle rapid growth, provide disciplines and leadership, and raise the appropriate financial capital to provide stability during all stages of the company's life.

In addition, Mr. Mueller is adept at providing projected financial, valuation and cash management modeling that supports strategic executive management of the company for day-to-day and projected future. He is regarded as a highly analytical decision maker, experienced in building companies, along with a proven history of generating corporate productivity. David Racz - Advisory Board: Mr. Racz has held global, senior-level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis.

Mr. Racz began his pharmaceutical career at Pfizer Pharmaceuticals where he became Vice President of Sales and Human Resources. Mr. Racz managed the largest expansion in Pfizer's sale force in history. Shortly thereafter, SmithKlineBeecham recruited Mr. Racz to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia and South Africa in Sales, Marketing and Research and Development.

Mr. Racz was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham. In 2002, Mr. Racz was recruited by Novartis Pharmaceuticals as Senior Vice President North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in Pharmaceutical Operations, Global Oncology, Manufacturing and R&D.